Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Molecules ; 23(6)2018 06 17.
Artículo en Inglés | MEDLINE | ID: mdl-29914211

RESUMEN

Honokiol (2-(4-hydroxy-3-prop-2-enyl-phenyl)-4-prop-2-enyl-phenol) and magnolol (4-Allyl-2-(5-allyl-2-hydroxy-phenyl)phenol) are the major active polyphenol constituents of Magnolia officinalis (Magnoliaceae) bark, which has been widely used in traditional Chinese medicine (Houpu Tang) for the treatment of various diseases, including anxiety, stress, gastrointestinal disorders, infection, and asthma. The aim of this study was to investigate the direct effects of honokiol and magnolol on hepatic CYP1A and 2C-mediated metabolism in vitro using rat liver microsomes and in vivo using the Sprague-Dawley rat model. Honokiol and magnolol inhibited in vitro CYP1A activity (probe substrate: phenacetin) more potently than CYP2C activity (probe substrate: diclofenac): The mean IC50 values of honokiol for the metabolism of phenacetin and diclofenac were 8.59 µM and 44.7 µM, while those of magnolol were 19.0 µM and 47.3 µM, respectively. Notably, the systemic exposure (AUC and Cmax) of phenacetin, but not of diclofenac, was markedly enhanced by the concurrent administration of intravenous honokiol or magnolol. The differential effects of the two phytochemicals on phenacetin and diclofenac in vivo pharmacokinetics could at least be partly attributed to their lower IC50 values for the inhibition of phenacetin metabolism than for diclofenac metabolism. In addition, the systemic exposure, CL, and Vss of honokiol and magnolol tended to be similar between the rat groups receiving phenacetin and diclofenac. These findings improve our understanding of CYP-mediated drug interactions with M. officinalis and its active constituents.


Asunto(s)
Compuestos de Bifenilo/administración & dosificación , Citocromo P-450 CYP1A1/metabolismo , Sistema Enzimático del Citocromo P-450/metabolismo , Diclofenaco/farmacocinética , Lignanos/administración & dosificación , Hígado/enzimología , Fenacetina/farmacocinética , Administración Intravenosa , Animales , Compuestos de Bifenilo/farmacología , Cromatografía Líquida de Alta Presión , Interacciones Farmacológicas , Regulación de la Expresión Génica/efectos de los fármacos , Lignanos/farmacología , Hígado/citología , Microsomas Hepáticos/enzimología , Estructura Molecular , Ratas , Ratas Sprague-Dawley
2.
J Toxicol Sci ; 42(4): 461-473, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28717105

RESUMEN

The herb Ephedra sinica (also known as Chinese ephedra or Ma Huang), used in traditional Chinese medicine, contains alkaloids identical to ephedrine and pseudoephedrine as its principal active constituents. Recent studies have reported that ephedrine has various side effects in the cardiovascular and nervous systems. In addition, herbal Ephedra, a plant containing many pharmacologically active alkaloids, principally ephedrine, has been reported to cause acute hepatitis. Many studies reported clinical cases, however, the cellular mechanism of liver toxicity by ephedrine remains unknown. In this study, we investigated hepatotoxicity and key regulation of mitophagy in ephedrine-treated LX-2 cells. Ephedrine triggered mitochondrial oxidative stress and depolarization. Mitochondrial swelling and autolysosome were observed in ephedrine-treated cells. Ephedrine also inhibited mitochondrial biogenesis, and the mitochondrial copy number was decreased. Parkin siRNA recovered the ephedrine-induced mitochondrial damage. Excessive mitophagy lead to cell death through imbalance of autophagic flux. Moreover, antioxidants and reducing Parkin level could serve as therapeutic targets for ephedrine-induced hepatotoxicity.


Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Efedrina/toxicidad , Células Estrelladas Hepáticas/efectos de los fármacos , Mitocondrias Hepáticas/efectos de los fármacos , Mitocondrias Hepáticas/metabolismo , Mitofagia/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Antioxidantes/uso terapéutico , Autofagia , Muerte Celular , Células Cultivadas , Enfermedad Hepática Inducida por Sustancias y Drogas/terapia , Ephedra sinica/química , Efedrina/aislamiento & purificación , Dosificación de Gen/efectos de los fármacos , Humanos , Lisosomas/efectos de los fármacos , Mitocondrias Hepáticas/genética , Mitocondrias Hepáticas/patología , Dilatación Mitocondrial/efectos de los fármacos , Terapia Molecular Dirigida , Biogénesis de Organelos , ARN Interferente Pequeño/efectos de los fármacos , Ubiquitina-Proteína Ligasas/genética
3.
Am J Chin Med ; 45(4): 813-832, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28514906

RESUMEN

This study used an integrated approach to investigate the effects of Gymnema sylvestre (GS) extract as a functional dietary supplement with a high-fat diet. This approach examined insulin resistance, the dysfunction of adipose tissue, and liver steatosis. Male C57BL/6J mice were fed a normal chow or high-fat diet (HFD) for the acute and chronic study, in addition to GS in different doses (100, 250 and 500[Formula: see text]mg/kg body weight). Their body composition changes, serum lipid and glucose parameters, adipose and liver tissue histology, and gene expression were measured. It was found that GS significantly suppressed the increase of body weight, serum levels of lipid, insulin and leptin, and adipose tissue, and liver inflammation. GS also demonstrated hypoglycemic effects due to the amylase inhibition activity. Our results support the existence of a relationship between the HFD induced insulin resistance, adipose dysfunction and liver steatosis. In conclusion, GS works as a functional dietary supplement with preventative effects against metabolic disorder.


Asunto(s)
Dieta Alta en Grasa/efectos adversos , Suplementos Dietéticos , Gymnema sylvestre , Enfermedades Metabólicas/tratamiento farmacológico , Enfermedades Metabólicas/prevención & control , Extractos Vegetales/administración & dosificación , Extractos Vegetales/farmacología , Animales , Glucemia/metabolismo , Modelos Animales de Enfermedad , Hipoglucemiantes , Insulina/metabolismo , Resistencia a la Insulina , Leptina/metabolismo , Lípidos/sangre , Masculino , Enfermedades Metabólicas/etiología , Enfermedades Metabólicas/metabolismo , Ratones Endogámicos C57BL
4.
Food Chem Toxicol ; 83: 183-92, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26116884

RESUMEN

In this study, we examined the mechanism underlying the effect of Saururus chinensis Baill (saururaceae) on hepatocellular carcinoma HepG2 cells. HepG2 cells and Chang cells were exposed to various concentrations of S. chinensis Baill extract (SC-E) for 24 h. SC-E affected more significantly HepG2 cells than Chang cells in terms of cell viability and ATP production. Therefore, current study examined detailed mechanism how SC-E affected HepG2 cell survival. We found that SC-E (75 and 150 µg/ml) induced apoptosis via oxidative stress. SC-E also caused CCAAT-enhancer-binding protein homologous protein (CHOP) activation by dissociating the binding immunoglobulin protein (BiP) from inositol-requiring 1α (IRE1α) in the endoplasmic reticulum (ER) and induced Bax, cytochrome c release to cytosol, caspase-3 activation, and poly ADP ribose polymerase (PARP) cleavage, resulting in HepG2 cell apoptosis. Furthermore, SC-E caused ER Ca(2+) leakage into the cytosol; ER dilation and mitochondrial membrane damage were observed in transmission electron microscopy (TEM). Taken together, our results demonstrated that SC-E induced cancer cell apoptosis specifically through ER stress.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Apoptosis/efectos de los fármacos , Carcinoma Hepatocelular/tratamiento farmacológico , Estrés del Retículo Endoplásmico/efectos de los fármacos , Neoplasias Hepáticas/tratamiento farmacológico , Extractos Vegetales/farmacología , Saururaceae/química , Antineoplásicos Fitogénicos/efectos adversos , Señalización del Calcio/efectos de los fármacos , Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/ultraestructura , Núcleo Celular/efectos de los fármacos , Núcleo Celular/metabolismo , Núcleo Celular/ultraestructura , Supervivencia Celular/efectos de los fármacos , Retículo Endoplásmico/efectos de los fármacos , Retículo Endoplásmico/metabolismo , Retículo Endoplásmico/ultraestructura , Metabolismo Energético/efectos de los fármacos , Células Hep G2 , Hepatocitos/efectos de los fármacos , Humanos , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/ultraestructura , Medicina Tradicional de Asia Oriental , Microscopía Electrónica de Transmisión , Membranas Mitocondriales/efectos de los fármacos , Membranas Mitocondriales/metabolismo , Membranas Mitocondriales/ultraestructura , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/efectos adversos , República de Corea
5.
Nat Prod Commun ; 9(6): 847-51, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25115097

RESUMEN

Murine rheumatoid arthritis models are often used to investigate the potential therapeutic effects of candidate drugs. The present study has been conducted in order to investigate the therapeutic efficacy of ascidian tunicate extracts in a collagen-induced arthritis DBA1/J mice model. Four types of formulas, ascidian tunicate extracts (ATE), crude ascidian tunicate glycans (ATEC), ascidian tunicate extracts with licorice extracts (ATEL), and crude ascidian tunicate glycans with licorice extracts (ATECL) were orally administered into DBA/1J mice for 3 weeks and paw edema and thickness were evaluated. Changes in inflammatory proteins and cytokines levels were monitored in hind leg tissues by Western blot and quantitative PCR analysis. The oral administration of ascidian tunicate extracts alleviated paw edema and improved the histological hind leg cartilage status. The extracts also reduced the matrix metalloproteinase-9 (MMP-9) protein and prostaglandin E synthase (PGES) levels. In addition, the extracts-treated groups showed increased interleukin-10 (IL-10) levels compared with the non-treated group. These findings suggest that orally administered ascidian tunicate extracts might have potential therapeutic effects for the treatment of rheumatoid arthritis.


Asunto(s)
Antiinflamatorios/uso terapéutico , Artritis Reumatoide/inducido químicamente , Colágeno/toxicidad , Extractos de Tejidos/uso terapéutico , Urocordados/química , Animales , Antiinflamatorios/química , Isoxazoles/uso terapéutico , Leflunamida , Ratones , Extractos de Tejidos/química
6.
Nat Prod Commun ; 8(11): 1609-14, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24427953

RESUMEN

Broussonetia papyrifera (L.) Vent. and Lonicera japonica Thunb. have been used in recent medicinal research for their antioxidative and anti-inflammatory properties. The present study investigated the therapeutic efficacy of B. papyrifera and L. japonica ethanolic extracts in a murine model of ovalbumin-induced asthma, in which intra-peritoneal (IP) injections and aerosol ovalbumin delivery were used to induce allergic asthma. Bronchioalveolar lavage fluid (BALF), serum samples, lungs and livers were collected from the experimental groups. In the groups treated with B. papyrifera and L. japonica extracts, CD3, CD4, serum IgE and IL-4 levels; activities of matrix metalloproteinase (MMP)-2 and MMP-9; and eotaxin levels in the BALF significantly decreased to near normal levels. Results of a histopathological analysis showed that the level of inflammation and mucous secretions reduced in the treated groups compared to the corresponding levels in the other groups. Moreover, results of a serum enzymatic analysis showed the non-toxic nature of the extracts in the B. papyrifera and L. japonica treated groups. Taken together, these results clearly indicate that the B. papyrifera and L. japonica extracts may be very effective against asthma and inflammation related diseases.


Asunto(s)
Asma/tratamiento farmacológico , Broussonetia , Lonicera , Fitoterapia , Extractos Vegetales/uso terapéutico , Animales , Asma/inmunología , Modelos Animales de Enfermedad , Femenino , Interleucina-4/análisis , Activación de Linfocitos , Metaloproteinasa 2 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Ratones , Ratones Endogámicos BALB C , Ovalbúmina/inmunología , Extractos Vegetales/toxicidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA